Cargando…

Expression Pattern of Long Non-coding RNA Growth Arrest-specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

BACKGROUND: Long non-coding RNA growth arrest-specific 5 (GAS5) is deregulated in many cancers because of its role in cell growth arrest and apoptosis. Additionally, GAS5 interacts with glucocorticoid receptor, making it a potential pharmacotranscription marker of glucocorticoid (GC) therapy. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gasic, Vladimir, Stankovic, Biljana, Zukic, Branka, Janic, Dragana, Dokmanovic, Lidija, Krstovski, Nada, Lazic, Jelena, Milosevic, Goran, Lucafò, Marianna, Stocco, Gabriele, Decorti, Giuliana, Pavlovic, Sonja, Kotur, Nikola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534956/ https://www.ncbi.nlm.nih.gov/pubmed/31156339 http://dx.doi.org/10.2478/jomb-2018-0038

Ejemplares similares

Pharmacogenomic Markers of Glucocorticoid Response in The Initial Phase of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2018)

Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment
por: Kotur, Nikola, et al.
Publicado: (2020)

Variants in TPMT, ITPA, ABCC4 and ABCB1 Genes As Predictors of 6-mercaptopurine Induced Toxicity in Children with Acute Lymphoblastic Leukemia
por: Milosevic, Goran, et al.
Publicado: (2018)

Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment
por: Pavlovic, Sonja, et al.
Publicado: (2019)

Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications
por: Stankovic, Biljana, et al.
Publicado: (2021)

Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection
por: Klaassen, Kristel, et al.
Publicado: (2020)

Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
por: Stanković, Biljana, et al.
Publicado: (2020)

Genome-Wide Association Study of COVID-19 Outcomes Reveals Novel Host Genetic Risk Loci in the Serbian Population
por: Zecevic, Marko, et al.
Publicado: (2022)

Application of targeted next generation sequencing for the mutational profiling of patients with acute lymphoblastic leukemia
por: Janic, Dragana, et al.
Publicado: (2020)

Association of Vitamin D, Zinc and Selenium Related Genetic Variants With COVID-19 Disease Severity
por: Kotur, Nikola, et al.
Publicado: (2021)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
por: Stojiljkovic, Maja, et al.
Publicado: (2012)

Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021)

UGT1A1 (TA)(n) Promoter Genotype: Diagnostic and Population Pharmacogenetic Marker in Serbia
por: Vukovic, M, et al.
Publicado: (2018)

Expression Profiles of Long Non-Coding RNA GAS5 and MicroRNA-222 in Younger AML Patients
por: Pavlovic, Djordje, et al.
Publicado: (2021)

Microbiota and Drug Response in Inflammatory Bowel Disease
por: Franzin, Martina, et al.
Publicado: (2021)

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
por: Lucafò, Marianna, et al.
Publicado: (2021)

Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?
por: Jelovac, Marina, et al.
Publicado: (2023)

Patient-derived organoids for therapy personalization in inflammatory bowel diseases
por: Lucafò, Marianna, et al.
Publicado: (2022)

Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2022)

Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021)

Significance of UGT1A1*28 Genotype in Patients with Advanced Liver Injury Caused By Chronic Hepatitis C
por: Jordovic, Jelena, et al.
Publicado: (2019)

Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients
por: Lucafò, Marianna, et al.
Publicado: (2019)

Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019)

Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease
por: Curci, Debora, et al.
Publicado: (2022)

Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events
por: Genova, Elena, et al.
Publicado: (2019)

Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease
por: Di Silvestre, Alessia, et al.
Publicado: (2019)

Multilocus Genotypes of Relevance for Drug Metabolizing Enzymes and Therapy with Thiopurines in Patients with Acute Lymphoblastic Leukemia
por: Stocco, Gabriele, et al.
Publicado: (2013)

Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease
por: Curci, Debora, et al.
Publicado: (2021)

A Validated HPLC–Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside
por: Franzin, Martina, et al.
Publicado: (2022)

5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
por: Pastore, Serena, et al.
Publicado: (2014)

Induced pluripotent stem cells as an innovative model to study drug induced pancreatitis
por: Genova, Elena, et al.
Publicado: (2021)

Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease
por: Dragasevic, Sanja, et al.
Publicado: (2022)

PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells
por: Zudeh, Giulia, et al.
Publicado: (2023)

Biomarkers for gastrointestinal adverse events related to thiopurine therapy
por: Zudeh, Giulia, et al.
Publicado: (2021)

Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants
por: Lucafò, Marianna, et al.
Publicado: (2019)

A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour Development
por: Byrd, Philip J., et al.
Publicado: (2016)

miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway
por: Lucafò, Marianna, et al.
Publicado: (2020)

Long Non-Coding RNA GAS5 and Intestinal MMP2 and MMP9 Expression: A Translational Study in Pediatric Patients with IBD
por: Lucafò, Marianna, et al.
Publicado: (2019)

Superficial Thrombophlebitis of the Breast (Mondor’s Disease): An Uncommon Localization of Common Disease
por: Obradovic, Katarina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uje1u5dcciakvmnr2uvr3nn7c5